Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "776.75",
    "chg": -9.75,
    "chgp": "-1.24%",
    "dir": -1,
    "prev_price": "786.50",
    "mcapval": "3,556.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0RB801010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.31 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharma. Sees Revised Market Assessment Amidst Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharma-upgraded-to-hold-by-marketsmojo-on-improving-fundamentals-3735181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharma_mojoScore_3735181.png",
        "date": "2025-11-28 10:05:28",
        "description": "Senores Pharma., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical parameters. This adjustment follows a period marked by notable growth in sales and profits, alongside a valuation that remains on the higher side relative to its peers."
      },
      {
        "title": "Senores Pharmaceuticals Hits New 52-Week High of Rs.832 Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-hits-new-52-week-high-at-rs832-3718318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3718318.png",
        "date": "2025-11-20 14:48:07",
        "description": "Senores Pharmaceuticals has reached a new 52-week high of Rs.832, marking a notable milestone in its stock performance amid a broadly positive market environment."
      },
      {
        "title": "Senores Pharmaceuticals Hits All-Time High Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-hits-all-time-high-on-20-nov-2025-3718277",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3718277.png",
        "date": "2025-11-20 14:14:58",
        "description": "Senores Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has reached an all-time high, marking a significant milestone in its market journey. The stock's recent performance reflects robust momentum, supported by consistent price strength and favourable trading patterns."
      },
      {
        "title": "Why is Senores Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-senores-pharma-fallingrising-3681692",
        "imagepath": "",
        "date": "2025-11-08 00:46:35",
        "description": "As of 07-Nov, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 822.30, reflecting a rise of 16.5 or 2.05%. The stock has recently hit a new 52-week and all-time high of Rs. 831.65 today, demonstrating strong performance with a 7.24% gain over the last two days. Additionally, it has outperformed its sector by 2.39%. The stock's performance over the past week shows a return of +6.82%, while it has achieved a remarkable +16.09% over the past month. The company has shown impressive financial health, with net sales growing at an annual rate of 85.60% and a net profit increase of 138.15%, contributing to positive investor sentiment and driving the stock's upward movement.\n\nIn the broader market context, while the Sensex has declined by 0.86% over the past week, Senores Pharmaceuticals has significantly outperformed this benchmark, indicating strong investor confidence in the company rela..."
      },
      {
        "title": "Are Senores Pharma. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-senores-pharma-latest-results-good-or-bad-3680589",
        "imagepath": "",
        "date": "2025-11-07 19:27:43",
        "description": "Senores Pharmaceuticals has reported notable financial results for the quarter ended September 2025, highlighting a significant operational performance. The company achieved net sales of ₹161.76 crores, reflecting a year-on-year growth of 60.75% and a sequential increase of 17.23%. This marks an all-time high for the company, indicating strong demand across its product portfolio. \n\nThe operating margin for the quarter expanded to 32.28%, up from 23.68% in the same quarter last year, showcasing improved operational efficiency and economies of scale as the company continues to grow. The profit after tax (PAT) also saw substantial growth, reaching ₹32.38 crores, which is a 152.18% increase year-on-year and a 64.12% rise sequentially. The PAT margin improved to 19.64%, further demonstrating the company's ability to convert revenue growth into profitability.\n\nIn terms of operational dynamics, the company has sho..."
      },
      {
        "title": "Senores Pharmaceuticals Hits New 52-Week High of Rs. 831.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-hits-new-52-week-high-of-rs-83165-3680045",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3680045.png",
        "date": "2025-11-07 15:44:41",
        "description": "Senores Pharmaceuticals achieved a new 52-week high of Rs. 831.65 on November 7, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has outperformed its sector and demonstrated resilience with consecutive gains, trading above key moving averages and showing significant recovery from its previous low."
      },
      {
        "title": "Senores Pharmaceuticals Soars to All-Time High, Signaling Unmatched Market Strength",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-soars-to-all-time-high-signaling-unmatched-market-strength-3679993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3679993.png",
        "date": "2025-11-07 15:07:25",
        "description": "Senores Pharmaceuticals has achieved an all-time high of Rs. 830.3, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has shown consistent upward momentum, gaining 8.28% over two days and outperforming the Sensex significantly year-to-date, highlighting the company's robust market strength and growth trajectory."
      },
      {
        "title": "Senores Pharmaceuticals Reports Record Financial Performance Amid Rising Interest Expenses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-financial-trend-improves-from-positive-to-outstanding-with-record-sales-and-profit-3678340",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_fintrenddot_3678340.png",
        "date": "2025-11-07 08:00:34",
        "description": "Senores Pharmaceuticals has reported record financial results for the quarter ending September 2025, with net sales of Rs 161.76 crore and a profit after tax of Rs 32.38 crore. Despite facing high interest expenses, the company has significantly outperformed the Sensex, showcasing its strong market position."
      },
      {
        "title": "How has been the historical performance of Senores Pharma.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-senores-pharma-3677438",
        "imagepath": "",
        "date": "2025-11-06 23:07:25",
        "description": "Answer:\nThe historical performance of Senores Pharma shows significant growth in various financial metrics from March 2024 to March 2025.\n\nBreakdown:\nSenores Pharma's net sales increased substantially from 214.52 Cr in March 2024 to 398.25 Cr in March 2025, reflecting strong operational growth. Total operating income followed the same trend, rising to 398.25 Cr from 214.52 Cr. However, raw material costs surged to 91.64 Cr from 31.96 Cr, and employee costs also rose to 60.37 Cr from 35.46 Cr, contributing to a total expenditure of 308.55 Cr, up from 172.92 Cr. Operating profit (PBDIT) improved significantly to 108.96 Cr from 44.42 Cr, with profit before tax reaching 70.57 Cr compared to 24.95 Cr the previous year. Profit after tax also saw an increase to 58.34 Cr from 32.71 Cr. The company's total assets grew to 1,208.19 Cr from 606.92 Cr, while total liabilities increased to 1,208.19 Cr from 606.92 Cr as w..."
      }
    ],
    "total": 151,
    "sid": "10039497",
    "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharma. Sees Revised Market Assessment Amidst Strong Financial Trends

2025-11-28 10:05:28

Senores Pharma., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical parameters. This adjustment follows a period marked by notable growth in sales and profits, alongside a valuation that remains on the higher side relative to its peers.

Senores Pharmaceuticals Hits New 52-Week High of Rs.832 Marking Significant Milestone

2025-11-20 14:48:07

Senores Pharmaceuticals has reached a new 52-week high of Rs.832, marking a notable milestone in its stock performance amid a broadly positive market environment.

Senores Pharmaceuticals Hits All-Time High Amid Strong Market Momentum

2025-11-20 14:14:58

Senores Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has reached an all-time high, marking a significant milestone in its market journey. The stock's recent performance reflects robust momentum, supported by consistent price strength and favourable trading patterns.

Why is Senores Pharma. falling/rising?

2025-11-08 00:46:35

As of 07-Nov, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 822.30, reflecting a rise of 16.5 or 2.05%. The stock has recently hit a new 52-week and all-time high of Rs. 831.65 today, demonstrating strong performance with a 7.24% gain over the last two days. Additionally, it has outperformed its sector by 2.39%. The stock's performance over the past week shows a return of +6.82%, while it has achieved a remarkable +16.09% over the past month. The company has shown impressive financial health, with net sales growing at an annual rate of 85.60% and a net profit increase of 138.15%, contributing to positive investor sentiment and driving the stock's upward movement. In the broader market context, while the Sensex has declined by 0.86% over the past week, Senores Pharmaceuticals has significantly outperformed this benchmark, indicating strong investor confidence in the company rela...

Are Senores Pharma. latest results good or bad?

2025-11-07 19:27:43

Senores Pharmaceuticals has reported notable financial results for the quarter ended September 2025, highlighting a significant operational performance. The company achieved net sales of ₹161.76 crores, reflecting a year-on-year growth of 60.75% and a sequential increase of 17.23%. This marks an all-time high for the company, indicating strong demand across its product portfolio. The operating margin for the quarter expanded to 32.28%, up from 23.68% in the same quarter last year, showcasing improved operational efficiency and economies of scale as the company continues to grow. The profit after tax (PAT) also saw substantial growth, reaching ₹32.38 crores, which is a 152.18% increase year-on-year and a 64.12% rise sequentially. The PAT margin improved to 19.64%, further demonstrating the company's ability to convert revenue growth into profitability. In terms of operational dynamics, the company has sho...

Senores Pharmaceuticals Hits New 52-Week High of Rs. 831.65

2025-11-07 15:44:41

Senores Pharmaceuticals achieved a new 52-week high of Rs. 831.65 on November 7, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has outperformed its sector and demonstrated resilience with consecutive gains, trading above key moving averages and showing significant recovery from its previous low.

Senores Pharmaceuticals Soars to All-Time High, Signaling Unmatched Market Strength

2025-11-07 15:07:25

Senores Pharmaceuticals has achieved an all-time high of Rs. 830.3, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has shown consistent upward momentum, gaining 8.28% over two days and outperforming the Sensex significantly year-to-date, highlighting the company's robust market strength and growth trajectory.

Senores Pharmaceuticals Reports Record Financial Performance Amid Rising Interest Expenses

2025-11-07 08:00:34

Senores Pharmaceuticals has reported record financial results for the quarter ending September 2025, with net sales of Rs 161.76 crore and a profit after tax of Rs 32.38 crore. Despite facing high interest expenses, the company has significantly outperformed the Sensex, showcasing its strong market position.

How has been the historical performance of Senores Pharma.?

2025-11-06 23:07:25

Answer: The historical performance of Senores Pharma shows significant growth in various financial metrics from March 2024 to March 2025. Breakdown: Senores Pharma's net sales increased substantially from 214.52 Cr in March 2024 to 398.25 Cr in March 2025, reflecting strong operational growth. Total operating income followed the same trend, rising to 398.25 Cr from 214.52 Cr. However, raw material costs surged to 91.64 Cr from 31.96 Cr, and employee costs also rose to 60.37 Cr from 35.46 Cr, contributing to a total expenditure of 308.55 Cr, up from 172.92 Cr. Operating profit (PBDIT) improved significantly to 108.96 Cr from 44.42 Cr, with profit before tax reaching 70.57 Cr compared to 24.95 Cr the previous year. Profit after tax also saw an increase to 58.34 Cr from 32.71 Cr. The company's total assets grew to 1,208.19 Cr from 606.92 Cr, while total liabilities increased to 1,208.19 Cr from 606.92 Cr as w...

View All News